Company Filing History:
5 out of 48 
3 out of 7 
2 out of 32 
Years Active: 2016-2025
Title: The Innovative Journey of Inventor Alexander Smith
Introduction
Alexander Smith, an accomplished inventor based in Apex, NC, has made significant contributions to the field of pharmaceuticals, amassing a remarkable portfolio of 14 patents. His work focuses on innovative therapeutic formulations aimed at improving patient care, particularly in pediatric populations.
Latest Patents
Among his most recent innovations are two notable patents. The first involves the therapeutic uses of sodium thiosulfate formulations. This patent describes the synthesis of anhydrous sodium thiosulfate derived from sodium sulfite, sulfur, and cetylpyridinium chloride. The pharmaceutical composition developed from this formulation includes a buffer and solvent, designed to mitigate ototoxicity in pediatric patients undergoing treatment with platinum-based chemotherapeutics.
The second patent revolves around the morphic forms of trilaciclib, highlighting an advantageous isolated morphic form of the compound. This innovation covers various forms, including the di-hydrochloride salt, aimed at enhancing its manufacturability and therapeutic potential.
Career Highlights
Throughout his career, Alexander Smith has been associated with prominent companies in the pharmaceutical industry, including G1 Therapeutics, Inc. and Fennec Pharmaceuticals, Inc. His efforts have relentlessly focused on developing advanced therapies that address critical health challenges faced by patients.
Collaborations
Collaboration has played a vital role in Smith's success. He has worked alongside notable colleagues such as Hannah S. White and Kevin Gene Peters, with whom he has shared insights and expertise, further driving innovation within the field.
Conclusion
Alexander Smith's journey as an inventor is marked by his dedication to creating impactful solutions in healthcare. His latest patents not only demonstrate his innovative spirit but also reflect his commitment to improving the quality of life for patients, particularly the vulnerable pediatric demographic. As he continues to advance his work, the output of his creativity and expertise is expected to yield even more breakthroughs in the pharmaceutical industry.